hasInternationalNonproprietaryName

P24556
predicate

Indicates that an entity (typically a pharmaceutical substance) is designated by a specific International Nonproprietary Name (INN) as its standardized generic name.

All labels observed (2)

Label Occurrences
hasInternationalNonproprietaryName canonical 22
hasNonproprietaryName 2

Description generation (PDg)

The one-sentence description above was generated by prompting gpt-5.1 with the predicate name and this instruction.

Instruction
Given a predicate that represents a relationship or action between entities, generate a one-sentence description explaining its meaning.  
# Instructions
Focus on describing the relationship, not the entities themselves. 
# Response Format
Begin the description with \' Indicates...\'
Input
Predicate: hasInternationalNonproprietaryName
Generated description
Indicates that an entity (typically a pharmaceutical substance) is designated by a specific International Nonproprietary Name (INN) as its standardized generic name.

Sample triples (24)

Subject Object
Spinraza Spinraza self-linksurface differs
surface form: nusinersen
Fampyra fampridine
Tecentriq Tecentriq self-linksurface differs
surface form: atezolizumab
Darzalex daratumumab
mAb114 ansuvimab
onasemnogene abeparvovec onasemnogene abeparvovec self-link
Tegsedi inotersen
fampridine fampridine
MabThera Rituxan
surface form: rituximab
Avsola infliximab-axxq
Onpattro patisiran NERFINISHED
Oxlumo lumasiran NERFINISHED
Amvuttra vutrisiran NERFINISHED
Xeljanz tofacitinib NERFINISHED
Tagrisso osimertinib
LOXO-292 selpercatinib NERFINISHED
Vitrakvi larotrectinib NERFINISHED
Retevmo selpercatinib NERFINISHED
Gleevec imatinib
Venclexta venetoclax NERFINISHED
Alecensa alectinib
infliximab-dyyb infliximab-dyyb via predicate surface "hasNonproprietaryName"
Andexxa andexanet alfa via predicate surface "hasNonproprietaryName" NERFINISHED
fam-trastuzumab deruxtecan trastuzumab deruxtecan NERFINISHED